| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |